BioGaia AB

BGLA

Company Profile

  • Business description

    BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

  • Contact

    Kungsbroplan 3A
    StockholmSE-112 27
    SWE

    T: +46 855529300

    E: [email protected]

    https://www.biogaia.se

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    238

Stocks News & Analysis

stocks

Meta earnings: Strong end to 2025 as AI monetization begins to show

Investors please with latest results.
stocks

Why doesn’t the market like the earnings from this US tech giant?

Good quarter with AI demand ramping.
stocks

Our Tesla fair value increases meaningfully

Progress on Robotaxi and Optimus shows real world AI growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,254.4011.100.12%
CAC 408,071.364.680.06%
DAX 4024,309.46513.33-2.07%
Dow JONES (US)48,972.0543.55-0.09%
FTSE 10010,171.7617.330.17%
HKSE27,968.09141.180.51%
NASDAQ23,530.76326.69-1.37%
Nikkei 22553,585.53226.820.43%
NZX 50 Index13,363.3349.54-0.37%
S&P 5006,939.3138.72-0.55%
S&P/ASX 2008,950.4027.200.30%
SSE Composite Index4,157.870.11-0.00%

Market Movers